Edge Pharma, LLC recalls LET Topical Gel, Lidocaine HCL / Epinepherine / Tetracaine HCl, 4%/0.05%/0.5%, 3 mL per syringe, Single Dose Syringe for
Recalled February 2, 2022 · FDA recall D-0437-2022 · Edge Pharma
Hazard
CGMP Deviations · FDA Class II
Units
26917 syringes
Sold at
nationwide
Description
CGMP Deviations
Product
LET Topical Gel, Lidocaine HCL / Epinepherine / Tetracaine HCl, 4%/0.05%/0.5%, 3 mL per syringe, Single Dose Syringe for Topical Use, Edge Pharma, LLC, 856 Hercules Dr. Colchester, VT, NDC 05446-0607-01
Manufacturer(s)
Edge Pharma, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →